Protara Therapeutics, Inc. Stock Forecast
High volatility in Protara Therapeutics, Inc. stock price on Thursday which ended trading at $3.05
(Updated on Apr 25, 2024)
The Protara Therapeutics, Inc. stock price gained 8.16% on the last trading day (Thursday, 25th Apr 2024), rising from $2.82 to $3.05. During the last trading day the stock fluctuated 10.42% from a day low at $2.76 to a day high of $3.05. The price has fallen in 6 of the last 10 days and is down by -1.29% for this period. Volume fell on the last day by -160 thousand shares and in total, 263 thousand shares were bought and sold for approximately $800.80 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.65 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 2.28% during the next 3 months and, with a 90% probability hold a price between $2.71 and $5.01 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
TARA Signals & Forecast
There are mixed signals in the stock today. The Protara Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $3.53. On a fall, the stock will find some support from the short-term average at $2.86. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 15.53%. Further rise is indicated until a new top pivot has been found.
Support, Risk & Stop-loss for Protara Therapeutics, Inc. stock
Protara Therapeutics, Inc. finds support from accumulated volume at $3.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.288 between high and low, or 10.42%. For the last week the stock has had daily average volatility of 11.00%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (TARA) For The Upcoming Trading Day Of Friday 26th
For the upcoming trading day on Friday, 26th we expect Protara Therapeutics, Inc. to open at $2.95, and during the day (based on 14 day Average True Range), to move between $2.73 and $3.37, which gives a possible trading interval of +/-$0.323 (+/-10.60%) up or down from last closing price. If Protara Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 21.20% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $3.00 (1.64%) than the resistance at $3.22 (5.57%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Protara Therapeutics, Inc. will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.99. We will update the financials statements for Protara Therapeutics, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 7.59% in the first trading day after earnings release.
Is Protara Therapeutics, Inc. stock A Buy?
Protara Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -1.206 Sell Candidate Unchanged
Predicted Opening Price for Protara Therapeutics, Inc. of Friday, April 26, 2024
| Fair opening price April 26, 2024 | Current price |
|---|---|
| $2.95 ( 3.15%) | $3.05 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for TARA
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 3.24 | 6.29 % | |
| R2 | 3.13 | 2.69 % | ||
| R1 | 3.06 | 0.459 % | ||
| Current price: | 3.05 | |||
| Support | S1 | 2.84 | -6.75 % | |
| S2 | 2.78 | -8.98 % | ||
| S3 | 2.67 | -12.59 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 3.63 | 19.02 % | |
| R2 | 3.43 | 12.46 % | ||
| R1 | 3.22 | 5.57 % | ||
| Current price | 3.05 | |||
| Support | S1 | 3.00 | -1.64% | |
| S2 | 2.82 | -7.54% | ||
| S3 | 2.75 | -9.84% |
FAQ
Click here for our free guide on how to buy Protara Therapeutics, Inc. Stock.
